Loss of bone density, which makes bones brittle and more prone to breaking, is the main symptom of osteoporosis. Millions of people around the globe are affected by it, especially older women, and it can significantly lower people’s quality of life. Fortunately, there are a number of therapies that can help manage the condition and lower the chance of fractures, such as an osteoporosis injection.
A Short Note On Osteoporosis
Understanding osteoporosis is a prerequisite for understanding how the disease is treated with injections. Our bones constantly disintegrate and reassemble themselves. When we are young, bone density increases because bone formation outpaces bone breakdown at a faster rate. The rate of bone formation may outpace bone breakdown as we mature, resulting in a loss of bone density. Osteoporosis patients experience a more severe decrease in bone density and brittleness, which increases the risk of fractures. While osteoporosis can affect anyone, elderly women—especially those who have undergone menopause—are more frequently affected. A sedentary lifestyle, poor calcium intake, and a family history of osteoporosis are additional risk factors.
Treatment Options
Osteoporosis can be treated in a number of ways, including through dietary modifications, prescription drugs, and osteoporosis injections. Lifestyle adjustments like regular exercise, a calcium- and vitamin D-rich diet, and quitting smoking can help to strengthen bones and lower the chance of fractures. There are numerous drugs that can be used to treat osteoporosis. These include selective estrogen receptor modulators (SERMs), which mimic the effects of estrogen in the body and help to maintain bone density, and bisphosphonates, which slow down the rate of bone deterioration. Other drugs include denosumab, which targets the cells that break down bone, and calcitonin, which also slows down bone deterioration.
Osteoporosis Injection
Osteoporosis injections are a relatively new treatment option for osteoporosis that have shown promising results. It functions by promoting bone growth, which aids in boosting bone density and lowering the chance of fractures. Teriparatide, a manufactured version of parathyroid hormone, is one such osteoporosis medication. Teriparatide is typically provided for up to two years through a daily subcutaneous injection. Teriparatide can greatly boost bone density and lower the risk of fractures in people with osteoporosis, according to studies.
Abaloparatide and romosozumab are two additional osteoporosis injection therapies. Similar to teriparatide, abaloparatide promotes bone growth in order to function. On the other hand, romosozumab functions by preventing the action of a protein that prevents bone formation. Both treatments are accessible to those who have osteoporosis and have shown encouraging outcomes in clinical trials.
